LAG 3 Inhibitor Clinical Trials Research Intelligence
21 déc. 2021 03h38 HE
|
KuicK Research
Delhi, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Global LAG 3 Inhibitors Trials Intelligence Report Highlights: Global LAG 3 Inhibitors Market DynamicsClinical Approaches to Target LAG 3 InhibitorsRole...
Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy
07 avr. 2021 08h00 HE
|
Immutep Limited
Sydney, AUSTRALIA, April 07, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for...